Ohr Pharmaceutical, Inc. (OHRP)

[realfast95]

OHRP now NBSE

short interview with CEO
Enough financing for 12-24 months, before trials

https://tdameritradenetwork.com/video/rB4AoWvoE9qBa_waRPYCOw

twitter
https://twitter.com/NeuBaseInc

NeuBase +4.3% after Einhorn disclosure
Jul. 16, 2019 6:38 PM ET|About: NeuBase Therapeutics, Inc. (NBSE)|By: Jason Aycock, SA News Editor

NeuBase Therapeutics (NASDAQ:NBSE) is up 4.3% after hours following an ownership disclosure from David Einhorn's Greenlight Capital.

In the filing, Einhorn discloses beneficial ownership of 1,538,462 shares of common stock, making up a 9% stake.

The stock closed up 2% today; it began trading as a combined company with Ohr Pharmaceuticals yesterday, following the two companies' merger.

https://seekingalpha.com/news/3478276-neubase-plus-4_3-percent-einhorn-disclosure